共 145 条
[1]
Siegel R(2012)Cancer statistics, 2012 CA Cancer J Clin 62 10-29
[2]
Naishadham D(2011)Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients Swiss Med Wkly. 141 w13275-468
[3]
Jemal A(2005)Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker Int J Cancer 117 460-320
[4]
Zhou F(2005)Cellular processing of platinum anticancer drugs Nat Rev Drug Discov 4 307-3255
[5]
Yu Z(2008)Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin Mol Cancer Ther 7 3247-1883
[6]
Jiang T(2012)Molecular mechanisms of cisplatin resistance Oncogene 31 1869-4925
[7]
Lv H(2009)Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin–DNA interstrand cross-links Biochemistry 48 4916-716
[8]
Yao R(2005)XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking Int J Mol Med 16 709-494
[9]
Liang J(2010)Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer Am J Clin Oncol 33 489-43
[10]
Hirano T(2013)Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations Pharmacogenom J 13 35-1703